10q10k10q10k.net
MILESTONE SCIENTIFIC INC.

MILESTONE SCIENTIFIC INC.MLSSEarnings & Financial Report

NYSE

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

NextApr 15, 2026

MLSS Q3 2025 Key Financial Metrics

Revenue

$2.4M

Gross Profit

$1.6M

Operating Profit

$-1.1M

Net Profit

$-1.2M

Gross Margin

69.5%

Operating Margin

-48.1%

Net Margin

-48.9%

YoY Growth

-6.1%

EPS

$-0.01

Financial Flow

MILESTONE SCIENTIFIC INC. Q3 2025 Financial Summary

MILESTONE SCIENTIFIC INC. reported revenue of $2.4M for Q3 2025, with a net profit of $-1.2M (-48.9% margin). Cost of goods sold was $719.2K, operating expenses totaled $2.8M.

Key Financial Metrics

Total Revenue$2.4M
Net Profit$-1.2M
Gross Margin69.5%
Operating Margin-48.1%
Report PeriodQ3 2025

MILESTONE SCIENTIFIC INC. Annual Revenue by Year

MILESTONE SCIENTIFIC INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $8.6M).

YearAnnual Revenue
2024$8.6M
2023$9.8M
2022$8.8M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$2.3M$2.2M$1.9M$2.5M$2.0M$2.2M$2.3M$2.4M
YoY Growth0.9%-13.4%-36.3%22.1%-10.9%-0.7%25.3%-6.1%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$11.4M$11.4M$12.0M$11.2M$9.8M$9.1M$8.1M$8.5M
Liabilities$3.4M$3.9M$4.1M$4.0M$4.0M$4.6M$4.7M$5.9M
Equity$8.0M$7.5M$8.0M$7.2M$5.8M$4.5M$3.3M$2.5M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-1.2M$-1.2M$783655$-973914$-1.5M$-1.0M$-1.8M$81775